Banner - NPPA Connect

Opinion|Videos|December 3, 2024

Psychosocial Burden and Quality of Life of Patients with Atopic Dermatitis

Author(s)Lisa Weiss, PA-C

Panelists discuss how atopic dermatitis significantly impacts patients' mental health, social relationships, and daily activities, creating substantial psychosocial burdens that can lead to anxiety, depression, and reduced quality of life.

Episodes in this series

1 KOL is featured in this series.

EP. 1 The Effect of Atopic Dermatitis Across Patient Populations

1 KOL is featured in this series.

EP. 2 Psychosocial Burden and Quality of Life of Patients with Atopic Dermatitis

1 KOL is featured in this series.

EP. 3 Balancing Patient Needs and Telemedicine Considerations

1 KOL is featured in this series.

EP. 4 Variation of Atopic Dermatitis Challenges in Children and Adults

1 KOL is featured in this series.

EP. 5 Significant Barriers and Unmet Needs for Patients With Atopic Dermatitis

1 KOL is featured in this series.

EP. 6 Clinical Challenges in Treating Atopic Dermatitis

1 KOL is featured in this series.

EP. 7 Differentiating Pediatric Atopic Dermatitis from Other Skin Conditions

1 KOL is featured in this series.

EP. 8 Unique Challenges and Considerations for Treating Pediatric Atopic Dermatitis

1 KOL is featured in this series.

EP. 9 Engaging Parents, Caregivers, and Schools in the Management of Pediatric Atopic Dermatitis

1 KOL is featured in this series.

EP. 10 New and Upcoming Therapies in Atopic Dermatitis

1 KOL is featured in this series.

EP. 11 Comparing and Contrasting the Current Armamentarium for Treating Atopic Dermatitis

1 KOL is featured in this series.

EP. 12 Patient Adherence and the Future of Atopic Dermatitis Treatment

1 KOL is featured in this series.

EP. 13 Providing Support for Comorbidities and Psychological Health in Patients with Atopic Dermatitis

1 KOL is featured in this series.

EP. 14 Patient Education and Key Considerations for Initiating Topical JAK Inhibitors

1 KOL is featured in this series.

EP. 15 Precision Medicine’s Effect on Atopic Dermatitis Treatment

EP. 16 Unveiling the Complexities of Atopic Dermatitis Care

EP. 16 Unveiling the Complexities of Atopic Dermatitis Care

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Skin Clearance and PsA Prevention with Biologics in Psoriasis

ByBruce Strober, MD, PhD

September 1st 2026

1 expert is featured in this series

Case 3: Redefining How We Classify Psoriasis Severity

ByTina Bhutani-Jacques, MD

August 28th 2026

1 expert is featured in this series

Why One Foam Works for Scalp and Body Psoriasis

ByTina Bhutani-Jacques, MD

August 28th 2026

Rezpegaldesleukin Improves Atopic Dermatitis in Phase 2b Trial

ByShannon Heaning, Content Associate

August 25th 2026

1 expert is featured in this series

Reading the Risankizumab Claims Data: Protopathic Bias and Study Limitations

ByBruce Strober, MD, PhD

August 25th 2026

Latest CME

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care

10 Skin Cancer Exam Tips

Taltz Plus Zepbound Show Durable Year 1 Efficacy in Psoriatic Disease

Don't Be Rash: Recognizing Pediatric Psoriasis and Its Arthritis Risk